Metformin directly suppresses atherosclerosis in normoglycaemic mice via haematopoietic adenosine monophosphate-activated protein kinase.

Cardiovascular Research
Anusha SeneviratneJoseph J Boyle

Abstract

Atherosclerotic vascular disease has an inflammatory pathogenesis. Heme from intraplaque haemorrhage may drive a protective and pro-resolving macrophage M2-like phenotype, Mhem, via AMPK and activating transcription factor 1 (ATF1). The antidiabetic drug metformin may also activate AMPK-dependent signalling. Hypothesis: Metformin systematically induces atheroprotective genes in macrophages via AMPK and ATF1, thereby suppresses atherogenesis. Normoglycaemic Ldlr-/- hyperlipidaemic mice were treated with oral metformin, which profoundly suppressed atherosclerotic lesion development (P < 5 × 10-11). Bone marrow transplantation from AMPK-deficient mice demonstrated that metformin-related atheroprotection required haematopoietic AMPK [analysis of variance (ANOVA), P < 0.03]. Metformin at a clinically relevant concentration (10 μM) evoked AMPK-dependent and ATF1-dependent increases in Hmox1, Nr1h2 (Lxrb), Abca1, Apoe, Igf1, and Pdgf, increases in several M2-markers and decreases in Nos2, in murine bone marrow macrophages. Similar effects were seen in human blood-derived macrophages, in which metformin-induced protective genes and M2-like genes, suppressible by si-ATF1-mediated knockdown. Microarray analysis comparing metformin with h...Continue Reading

Associated Datasets

References

Oct 16, 1999·Circulation Research·Z MallatA Tedgui
Jul 5, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Aksam J MerchedLawrence Chan
Jul 15, 2006·Journal of Lipid Research·Mathijs GroenewegMenno P J de Winther
Jan 4, 2007·The American Journal of Pathology·Vinay K BhatiaDorian O Haskard
Jan 4, 2007·The Journal of Clinical Investigation·Frank TackeGwendalyn J Randolph
Mar 12, 2008·Nature Clinical Practice. Endocrinology & Metabolism·Shi Fang YanAnn Marie Schmidt
Sep 12, 2008·The New England Journal of Medicine·Rury R HolmanH Andrew W Neil
Dec 4, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Duygu SagJill Suttles
Jan 24, 2009·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Karin PerssonXi-Ming Yuan
Feb 24, 2009·The American Journal of Pathology·Joseph J BoyleDorian O Haskard
Sep 18, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Ziad Mallat
Jan 22, 2010·Clinical Science·Sean L McGee, Mark Hargreaves
Aug 27, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Joseph J BoyleDorian O Haskard
Nov 30, 2012·Cardiovascular Drugs and Therapy·Hannah J WhittingtonMihaela M Mocanu
Jul 13, 2013·Proceedings of the National Academy of Sciences of the United States of America·Andrew R OsterburgGeorge F Babcock
Oct 19, 2013·Proceedings of the National Academy of Sciences of the United States of America·Ronald G TompkinsRonald W Davis
Mar 14, 2014·The Lancet. Diabetes & Endocrinology·David PreissNaveed Sattar
Apr 18, 2014·Arteriosclerosis, Thrombosis, and Vascular Biology·Ann Marie Schmidt
Dec 3, 2014·Cell Metabolism·Marc ForetzBenoit Viollet
Dec 21, 2014·Journal of the American Heart Association·Farshad ForouzandehR Wayne Alexander
Jul 29, 2015·Nature Reviews. Endocrinology·Antje GartenWieland Kiess
Oct 9, 2015·Methods in Molecular Biology·Vinatha Sreeramkumar, Andrés Hidalgo
Apr 15, 2016·Cell Metabolism·Navdeep S ChandelMichael Pollak
Aug 18, 2016·Circulation Research·Joana R ViolaOliver Soehnlein
Feb 27, 2017·The Cochrane Database of Systematic Reviews·Clement LoSophia Zoungas

❮ Previous
Next ❯

Citations

Mar 9, 2021·Cardiovascular Research·Ian P SaltMorgan D Fullerton
Apr 16, 2021·Frontiers in Cell and Developmental Biology·André R A MarquesOtília V Vieira
May 27, 2021·Atherosclerosis·Aikaterini GatsiouKonstantinos Stellos
Jun 25, 2021·Frontiers in Immunology·Xiaojun FengJianping Weng

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.